A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice

Publication date: Available online 28 June 2020Source: Nanomedicine: Nanotechnology, Biology and MedicineAuthor(s): Rajnish Sahu, Saurabh Dixit, Richa Verma, Skyla A. Duncan, Mamie T. Coats, Guillermo Giambartolomei, Shree R. Singh, Vida A. Dennis
Source: Nanomedicine: Nanotechnology, Biology and Medicine - Category: Nanotechnology Source Type: research